A new orally bioavailable dual adenosine A2B/A3 receptor antagonist with therapeutic potential

被引：26
作者：
Press, NJ
Taylor, RJ
Fullerton, JD
Tranter, P
McCarthy, C
Keller, TH
Brown, L
Cheung, R
Christie, J
Haberthuer, S
Hatto, JDI
Keenan, M
Mercer, MK
Press, NE
Sahri, H
Tuffnell, AR
Tweed, M
Fozard, JR
机构：
[1] Novartis Inst Biomed Res, Resp Dis Area, Horsham RH12 5AB, W Sussex, England
[2] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland
[3] Novartis Inst Trop Dis Pte Ltd, Singapore 138670, Singapore
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 12期
关键词：
adenosine; A2B; A3; adenosine receptor antagonist; asthma; aminothiazole;
D O I：
10.1016/j.bmcl.2005.04.021
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
The synthesis and SAR of 5 -heterocycle- substituted aminothiazole adenosine receptor antagonists is described. Several compounds show high affinity and selectivity for the A(2B) and A(3) receptors. One compound (5f) shows good ADME properties in the rat and as such may be an important new compound in testing the current hypotheses proposing a therapeutic role for a dual A(2B)/A(3) antagonist in allergic diseases. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码：3081 / 3085
页数：5
相关论文
共 34 条
  • [1] Recent developments in the field of A3 adenosine receptor antagonists
    Baraldi, PG
    Tabrizi, MA
    Fruttarolo, F
    Bovero, A
    Avitabile, B
    Preti, D
    Romagnoli, R
    Merighi, S
    Gessi, S
    Varani, K
    Borea, PA
    [J]. DRUG DEVELOPMENT RESEARCH, 2003, 58 (04) : 315 - 329
  • [2] Impact of endogenous adenosine on airway hyperreactivity
    Blackburn, MR
    Young, HWJ
    [J]. DRUG DEVELOPMENT RESEARCH, 2003, 58 (04) : 472 - 478
  • [3] Coward WR, 1998, CLIN EXP ALLERGY, V28, P42
  • [4] Adenosine A3 receptors on human eosinophils mediate inhibition of degranulation and superoxide anion release
    Ezeamuzie, CI
    Philips, E
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1999, 127 (01) : 188 - 194
  • [5] FEOKTISTOV I, 1997, DRUG DEVELOP RES, V39, P333
  • [6] Fozard John R, 2002, Curr Opin Investig Drugs, V3, P69
  • [7] Adenosine receptor ligands: Potential as therapeutic agents in asthma and COPD
    Fozard, JR
    Hannon, JP
    [J]. PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (02) : 111 - 114
  • [8] The case for a role for adenosine in asthma: almost convincing?
    Fozard, JR
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2003, 3 (03) : 264 - 269
  • [9] Adenosine receptors as targets for drug development
    Fredholm, BB
    [J]. DRUG NEWS & PERSPECTIVES, 2003, 16 (05) : 283 - 289
  • [10] MOLECULAR CHARACTERIZATION OF A HUMAN BRAIN ADENOSINE-A2 RECEPTOR
    FURLONG, TJ
    PIERCE, KD
    SELBIE, LA
    SHINE, J
    [J]. MOLECULAR BRAIN RESEARCH, 1992, 15 (1-2): : 62 - 66
1234